Niacinamide (topical, 5%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Niacinamide (topical, 5%), covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients [EARLY_Phase 1]